Stability of buffer-free freeze-dried formulations: A feasibility study of a monoclonal antibody at high protein concentrations.
暂无分享,去创建一个
Patrick Garidel | P. Garidel | Sven Bahrenburg | Benjamin Pevestorf | Sven Bahrenburg | Benjamin Pevestorf
[1] B. Yeung,et al. Physical Stability of Protein Pharmaceuticals , 2010 .
[2] D. Brems,et al. Self-buffering antibody formulations. , 2008, Journal of pharmaceutical sciences.
[3] R. Suryanarayanan,et al. Glycine Crystallization in Frozen and Freeze-dried Systems: Effect of pH and Buffer Concentration , 2007, Pharmaceutical Research.
[4] M. Mulkerrin,et al. Influence of Histidine on the Stability and Physical Properties of a Fully Human Antibody in Aqueous and Solid Forms , 2003, Pharmaceutical Research.
[5] P. Matejtschuk. Lyophilization of proteins. , 2007, Methods in molecular biology.
[6] Patrick Garidel,et al. Strategies for the Assessment of Protein Aggregates in Pharmaceutical Biotech Product Development , 2010, Pharmaceutical Research.
[7] J H Crowe,et al. Trehalose and sucrose protect both membranes and proteins in intact bacteria during drying , 1995, Applied and environmental microbiology.
[8] P. Barber. Absorption and scattering of light by small particles , 1984 .
[9] A. Pekar,et al. Opalescent Appearance of an IgG1 Antibody at High Concentrations and Its Relationship to Noncovalent Association , 2004, Pharmaceutical Research.
[10] P. Garidel,et al. Microscopic Methods for Particle Characterization in Protein Pharmaceuticals , 2012 .
[11] M. Tomita,et al. Sensitized photooxidation of histidine and its derivatives. Products and mechanism of the reaction. , 1969, Biochemistry.
[12] W. Jiskoot,et al. Flow Imaging Microscopy for Protein Particle Analysis—A Comparative Evaluation of Four Different Analytical Instruments , 2013, The AAPS Journal.
[13] M. Pikal,et al. Formulation and stability of freeze-dried proteins: effects of moisture and oxygen on the stability of freeze-dried formulations of human growth hormone. , 1992, Developments in biological standardization.
[14] Michael J. Pikal,et al. Thermophysical Properties of Pharmaceutically Compatible Buffers at Sub-Zero Temperatures: Implications for Freeze-Drying , 2002, Pharmaceutical Research.
[15] I. Roy,et al. Effect of trehalose on protein structure , 2008, Protein science : a publication of the Protein Society.
[16] M. Pons,et al. Influence of the Hofmeister anions on protein stability as studied by thermal denaturation and chemical shift perturbation. , 2007, Biochemistry.
[17] Steven J Shire,et al. Challenges in the development of high protein concentration formulations. , 2004, Journal of pharmaceutical sciences.
[18] Michael J Pikal,et al. Effect of sorbitol and residual moisture on the stability of lyophilized antibodies: Implications for the mechanism of protein stabilization in the solid state. , 2005, Journal of pharmaceutical sciences.
[19] J. Loeb. DONNAN EQUILIBRIUM AND THE PHYSICAL PROPERTIES OF PROTEINS , 1921, The Journal of general physiology.
[20] Chung C. Hsu,et al. Effect of Moisture on the Stability of a Lyophilized Humanized Monoclonal Antibody Formulation , 2001, Pharmaceutical Research.
[21] Diwakar Shukla,et al. Molecular level insight into intra-solvent interaction effects on protein stability and aggregation. , 2011, Advanced drug delivery reviews.
[22] G. Winter,et al. Systematic investigation of the effect of lyophilizate collapse on pharmaceutically relevant proteins I: stability after freeze-drying. , 2010, Journal of pharmaceutical sciences.
[23] Theodore W Randolph,et al. Rational design of stable lyophilized protein formulations: theory and practice. , 2002, Pharmaceutical biotechnology.
[24] Jonida Basha,et al. Effect of protein and solution properties on the donnan effect during the ultrafiltration of proteins , 2011, Biotechnology progress.
[25] Frederick George Donnan,et al. Theory of membrane equilibria and membrane potentials in the presence of non-dialysing electrolytes. A contribution to physical-chemical physiology , 1995 .
[26] J. Davagnino,et al. Mapping of solution components, pH changes, protein stability and the elimination of protein precipitation during freeze-thawing of fibroblast growth factor 20. , 2009, International journal of pharmaceutics.
[27] Liang-Yu Shih,et al. Rational design of lyophilized high concentration protein formulations-mitigating the challenge of slow reconstitution with multidisciplinary strategies. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[28] Wouter Olthuis,et al. Characterization of proteins by means of their buffer capacity, measured with an ISFET-based coulometric sensor-actuator system , 1994 .
[29] Malgorzata B. Tracka,et al. Specific ion and buffer effects on protein-protein interactions of a monoclonal antibody. , 2015, Molecular pharmaceutics.
[30] David Ouellette,et al. Mechanism of protein stabilization by sugars during freeze-drying and storage: native structure preservation, specific interaction, and/or immobilization in a glassy matrix? , 2005, Journal of pharmaceutical sciences.
[31] J L Cleland,et al. A specific molar ratio of stabilizer to protein is required for storage stability of a lyophilized monoclonal antibody. , 2001, Journal of pharmaceutical sciences.
[32] S. Frokjaer,et al. Pharmaceutical Formulation Development Of Peptides And Proteins , 2009 .
[33] D. Singodia,et al. Excipient Selection In Parenteral Formulation Development , 2013 .
[34] S. Ausar,et al. Formulation, stability and immunogenicity of a trivalent pneumococcal protein vaccine formulated with aluminum salt adjuvants. , 2012, Vaccine.
[35] M. Pikal,et al. Mechanisms of protein stabilization in the solid state. , 2009, Journal of pharmaceutical sciences.
[36] Sandeep Nema,et al. Excipients and Their Role in Approved Injectable Products: Current Usage and Future Directions , 2011, PDA Journal of Pharmaceutical Science and Technology.
[37] J. Carpenter,et al. Lyophilization-induced protein denaturation in phosphate buffer systems: monomeric and tetrameric beta-galactosidase. , 2001, Journal of pharmaceutical sciences.
[38] P. Garidel,et al. A rapid, sensitive and economical assessment of monoclonal antibody conformational stability by intrinsic tryptophan fluorescence spectroscopy , 2008, Biotechnology journal.
[39] K. Hellingwerf,et al. Binding of hydrogen-citrate to photoactive yellow protein is affected by the structural changes related to signaling state formation. , 2012, The journal of physical chemistry. B.
[40] L. Rey,et al. Freeze-drying/lyophilization of pharmaceutical and biological products , 2004 .
[41] C. Tropea,et al. Light Scattering from Small Particles , 2003 .
[42] Patrick Garidel,et al. Systematic investigation of the effect of lyophilizate collapse on pharmaceutically relevant proteins, part 2: stability during storage at elevated temperatures. , 2012, Journal of pharmaceutical sciences.
[43] M. Eisenstein,et al. A citrate‐binding site in calmodulin , 1998, Journal of molecular recognition : JMR.
[44] S. Jacob,et al. Stability of proteins in aqueous solution and solid state , 2006 .
[45] A. Shrake,et al. Decrease in stability of human albumin with increase in protein concentration. , 1988, The Journal of biological chemistry.
[46] Wei Wang,et al. Rational Choice of Excipients for Use in Lyophilized Formulations , 2007 .
[47] Scott Lute,et al. Impact of controlled ice nucleation on process performance and quality attributes of a lyophilized monoclonal antibody. , 2013, International journal of pharmaceutics.
[48] Patrick Garidel,et al. Buffer-free therapeutic antibody preparations provide a viable alternative to conventionally buffered solutions: from protein buffer capacity prediction to bioprocess applications. , 2015, Biotechnology journal.
[49] Sandeep Yadav,et al. Weak interactions govern the viscosity of concentrated antibody solutions: high-throughput analysis using the diffusion interaction parameter. , 2012, Biophysical journal.
[50] Tim J Kamerzell,et al. Protein-excipient interactions: mechanisms and biophysical characterization applied to protein formulation development. , 2011, Advanced drug delivery reviews.
[51] Susanne Hostrup,et al. Recent trends in stabilising peptides and proteins in pharmaceutical formulation – considerations in the choice of excipients , 2009, Expert opinion on drug delivery.
[52] I. Trelea,et al. Effect of controlled ice nucleation on primary drying stage and protein recovery in vials cooled in a modified freeze-dryer. , 2009, Journal of biomechanical engineering.
[53] Tim J Kamerzell,et al. Polar solvents decrease the viscosity of high concentration IgG1 solutions through hydrophobic solvation and interaction: formulation and biocompatibility considerations. , 2013, Journal of pharmaceutical sciences.
[54] S. Leigh,et al. Photosensitizers form in histidine buffer and mediate the photodegradation of a monoclonal antibody. , 2011, Journal of pharmaceutical sciences.
[55] O. Siggaard‐Andersen,et al. Ionic binding, net charge, and Donnan effect of human serum albumin as a function of pH. , 1993, Clinical chemistry.
[56] Patrick Garidel,et al. Buffer capacity of biologics—from buffer salts to buffering by antibodies , 2013, Biotechnology progress.
[57] S. Apte,et al. The effect of buffers on protein conformational stability , 2004 .
[58] G. Winter,et al. Systematic investigation of the effect of lyophilizate collapse on pharmaceutically relevant proteins III: collapse during storage at elevated temperatures. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[59] Satoshi Ohtake,et al. Interactions of formulation excipients with proteins in solution and in the dried state. , 2011, Advanced drug delivery reviews.
[60] Sandeep Yadav,et al. The influence of charge distribution on self-association and viscosity behavior of monoclonal antibody solutions. , 2012, Molecular pharmaceutics.
[61] Michael J. Pikal,et al. Rational Design of Stable Lyophilized Protein Formulations: Some Practical Advice , 1997, Pharmaceutical Research.
[62] R Geidobler,et al. Controlled ice nucleation in the field of freeze-drying: fundamentals and technology review. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[63] M. Pikal,et al. Effect of Initial Buffer Composition on pH Changes During Far-From-Equilibrium Freezing of Sodium Phosphate Buffer Solutions , 2004, Pharmaceutical Research.
[64] W. Wang,et al. Lyophilization and development of solid protein pharmaceuticals. , 2000, International journal of pharmaceutics.
[65] T. Arakawa,et al. Developments and Challenges for mAb-Based Therapeutics , 2013 .
[66] W Wang,et al. Instability, stabilization, and formulation of liquid protein pharmaceuticals. , 1999, International journal of pharmaceutics.
[67] M. Parkes,et al. The effect of buffer solution choice on protein adsorption and lubrication , 2014 .
[68] Qiang Shao,et al. Counterion Effects on the Denaturing Activity of Guanidinium Cation to Protein. , 2012, Journal of chemical theory and computation.
[69] B. Chang,et al. Physical stabilization of proteins in aqueous solution. , 2002, Pharmaceutical biotechnology.
[70] Patrizia Restani,et al. The safety of pharmaceutical excipients. , 2003, Farmaco.
[71] J. Davagnino,et al. Effects of pH and arginine on the solubility and stability of a therapeutic protein (Fibroblast Growth Factor 20): relationship between solubility and stability. , 2009, Current pharmaceutical biotechnology.
[72] C Russell Middaugh,et al. Formulation design and high-throughput excipient selection based on structural integrity and conformational stability of dilute and highly concentrated IgG1 monoclonal antibody solutions. , 2012, Journal of pharmaceutical sciences.
[73] J. Goldstein,et al. Effects of arginine on photostability and thermal stability of IgG1 monoclonal antibodies. , 2009, Current pharmaceutical biotechnology.
[74] G. Reeder,et al. Development of a Stable Freeze-dried Formulation of Recombinant Human Interleukin-1 Receptor Antagonist , 1996, Pharmaceutical Research.
[75] Theodore W Randolph,et al. Protein-solute interactions affect the outcome of ultrafiltration/diafiltration operations. , 2004, Journal of pharmaceutical sciences.
[76] R. de Ruiter,et al. Lyophilization of biotechnology products. , 1994, PDA journal of pharmaceutical science and technology.
[77] T. Laursen,et al. Pain perception after subcutaneous injections of media containing different buffers. , 2006, Basic & clinical pharmacology & toxicology.
[78] Steven J Shire,et al. Reversible self-association increases the viscosity of a concentrated monoclonal antibody in aqueous solution. , 2005, Journal of pharmaceutical sciences.
[79] P. Garidel,et al. Process Development and Manufacturing of Therapeutic Antibodies , 2014 .
[80] Gerhard Winter,et al. Can controlled ice nucleation improve freeze-drying of highly-concentrated protein formulations? , 2013, Journal of pharmaceutical sciences.
[81] R. L. Davison,et al. Accelerated extractable studies of borosilicate glass containers. , 1989, Journal of parenteral science and technology : a publication of the Parenteral Drug Association.
[82] S. Krishnan,et al. Development of stable lyophilized protein drug products. , 2012, Current pharmaceutical biotechnology.